Biothera BT-CL-PGG-LCA0821
Laufzeit: 01.01.2009 - 31.12.2011
Kurzfassung
A phase II, randomized, efficacy and safety study of Imprime PGG injection in combination with Bevacizumab and concomitant Paclitaxel and Carboplatin therapy in patients with previously untreated (Stage IIIB or IV) NSCLC
